| |
Original Artikel |
Datum |
Titel |
Autoren Max. 6 Autoren |
| 1 |
[GO] |
2025―Feb―11 |
For adults working in non-healthcare settings, how does a test-based attendance strategy compare with 10-day self-isolation following exposure to SARS-CoV-2? |
Selena Ryan-Vig, Agustín Ciapponi |
| 2 |
[GO] |
2024―Nov―22 |
What are the effects of favipiravir for treating adults with COVID-19? |
Amin Sharifan |
| 3 |
[GO] |
2023―Sep―05 |
For non-hospitalized people with COVID-19 at risk of progression, do prophylactic anticoagulants improve outcomes? |
Sera Tort, Mario Cruciani |
| 4 |
[GO] |
2023―Sep―05 |
What are the effects of antiplatelet agents for the treatment of adults with COVID-19? |
Sera Tort, Agustín Ciapponi |
| 5 |
[GO] |
2023―Aug―08 |
For adults with COVID-19, what are the effects of the interleukin-6 blocking agents tocilizumab and sarilumab? |
Sera Tort, Sarah El-Nakeep |
| 6 |
[GO] |
2023―Jun―13 |
For adults with COVID-19, does obesity affect outcomes? |
Sera Tort, Agustín Ciapponi |
| 7 |
[GO] |
2023―Feb―06 |
For people with mild COVID-19, how does convalescent plasma compare with placebo or with standard plasma? |
Sera Tort, Agustín Ciapponi |
| 8 |
[GO] |
2023―Feb―06 |
What are the effects of convalescent plasma for people with moderate to severe COVID-19? |
Sera Tort, Agustín Ciapponi |
| 9 |
[GO] |
2023―Jan―31 |
For people with asymptomatic SARS-CoV-2 infection or mild COVID-19, what are the benefits and harms of remdesivir? |
Agustín Ciapponi, Sera Tort |
| 10 |
[GO] |
2023―Jan―31 |
For adults with moderate/severe COVID-19, what are the effects of hyperimmune immunoglobulin, specifically equine polyclonal antibodies (EpAbs)? |
Agustín Ciapponi, Sera Tort |
| 11 |
[GO] |
2023―Jan―31 |
What are the benefits and harms of hyperimmune immunoglobulin (hIVIG) from human plasma for treating adults with moderate/severe COVID-19? |
Agustín Ciapponi, Amin Sharifan |
| 12 |
[GO] |
2023―Jan―31 |
What are the effects of remdesivir for treating moderate to severe COVID-19? |
Sera Tort, Agustín Ciapponi |
| 13 |
[GO] |
2023―Jan―27 |
Does hormonal contraception increase the risk of thromboembolism in women with COVID-19? |
Agustín Ciapponi, Amin Sharifan |
| 14 |
[GO] |
2022―Dez―09 |
What are the benefits and risks of protein subunit vaccines for preventing COVID-19? |
Agustín Ciapponi, Amin Sharifan |
| 15 |
[GO] |
2022―Dez―09 |
What are the benefits and risks of non-replicant viral vector vaccines for preventing COVID-19? |
Agustín Ciapponi, Amin Sharifan |
| 16 |
[GO] |
2022―Dez―09 |
What are the benefits and risks of inactivated virus vaccines for preventing COVID-19? |
Agustín Ciapponi, Amin Sharifan |
| 17 |
[GO] |
2022―Dez―09 |
What are the benefits and risks of RNA-based vaccines for preventing COVID-19? |
Agustín Ciapponi, Amin Sharifan |
| 18 |
[GO] |
2022―Dez―06 |
What is the accuracy of immunoglobulin G (IgG) and IgM antibody tests for the detection of past SARS-CoV-2 infection? |
Agustín Ciapponi, Sera Tort |
| 19 |
[GO] |
2022―Nov―24 |
What is the accuracy of immunoglobulin G (IgG) and IgM antibody tests for the detection of current SARS-CoV-2 infection? |
Sera Tort, Agustín Ciapponi |
| 20 |
[GO] |
2022―Nov―21 |
For adults hospitalized with acute or suspected COVID-19, what are the benefits and harms of systemic corticosteroids? |
Sera Tort, Agustín Ciapponi |
| 21 |
[GO] |
2022―Sep―27 |
What are the effects of nirmatrelvir combined with ritonavir for treating COVID-19 in the outpatient setting? |
Sera Tort, Agustín Ciapponi |
| 22 |
[GO] |
2022―Sep―19 |
What are the benefits and harms of fluvoxamine for adults with mild COVID-19? |
Agustín Ciapponi, Sera Tort |
| 23 |
[GO] |
2022―Aug―18 |
What evidence is available on vaccines against SARS-CoV-2 in people at higher risk of lower immune response? |
Sera Tort, Agustín Ciapponi |
| 24 |
[GO] |
2022―Aug―04 |
What evidence is available on interventions to increase COVID-19 vaccine uptake or decrease COVID-19 vaccine hesitancy? |
Sera Tort, Agustín Ciapponi |
| 25 |
[GO] |
2022―Jul―28 |
What is the accuracy of rapid, point-of-care antigen tests for the diagnosis of SARS-CoV-2 infection? |
Sera Tort, Smitha Bhat |
| 26 |
[GO] |
2022―Jul―06 |
In invasively ventilated people with COVID-19 and acute respiratory distress syndrome (ARDS), what are the effects of enabling early spontaneous breathing activity? |
Sera Tort, Agustín Ciapponi |
| 27 |
[GO] |
2022―Jul―04 |
For adults with mild or moderate to severe symptomatic COVID-19, what are the effects of ivermectin? |
Sera Tort, Agustín Ciapponi |
| 28 |
[GO] |
2022―Jun―22 |
Can pre-exposure SARS-CoV-2-neutralising monoclonal antibodies help prevent COVID-19? |
Sera Tort, Agustín Ciapponi |
| 29 |
[GO] |
2022―Jun―22 |
Can postexposure SARS-CoV-2-neutralising monoclonal antibodies help prevent COVID-19? |
Sera Tort, Agustín Ciapponi |
| 30 |
[GO] |
2022―Jun―15 |
What are the effects of janus kinase (JAK) inhibitors for people with moderate to severe COVID-19? |
Sera Tort, Agustín Ciapponi |
| 31 |
[GO] |
2022―Jun―13 |
What evidence is available on unintended health and societal consequences of measures implemented in the school setting to contain the COVID-19 pandemic? |
Sera Tort, Agustín Ciapponi |
| 32 |
[GO] |
2022―Jun―08 |
What is the accuracy of World Health Organization (WHO)-specified and related COVID-19 symptoms for the diagnosis of COVID-19? |
Sera Tort, Agustín Ciapponi |
| 33 |
[GO] |
2022―Mai―25 |
What is the accuracy of chest computed tomography (CT) and chest X-ray for the diagnosis of COVID-19? |
Sera Tort, Kwun M Fong |
| 34 |
[GO] |
2022―Mai―16 |
For adult workers outside healthcare settings after contact with an infected person, how does a test-based attendance strategy compare with a standard 10-day self-isolation in terms of rates of SARS-CoV-2 infection? |
Sera Tort, Agustín Ciapponi |
| 35 |
[GO] |
2022―Mrz―15 |
How do higher-dose anticoagulants compare with lower-dose for people with moderate to severe COVID-19? |
Sera Tort, Amin Sharifan |
| 36 |
[GO] |
2022―Mrz―11 |
For people with mild COVID-19, what are the effects of inhaled corticosteroids? |
Sera Tort, Agustín Ciapponi |
| 37 |
[GO] |
2022―Feb―07 |
Do measures implemented in the school setting help contain the COVID-19 pandemic? |
Sera Tort, Karen Pettersen |
| 38 |
[GO] |
2022―Feb―04 |
For people with moderate, severe or critical COVID-19 illness, what are the effects of interleukin 1 (IL-1) blocking agents (anakinra or canakinumab)? |
Sera Tort, Agustín Ciapponi |
| 39 |
[GO] |
2021―Okt―26 |
For adults hospitalized with moderate to severe COVID-19, what are the effects of azithromycin? |
Jane Burch, Sera Tort |
| 40 |
[GO] |
2021―Okt―26 |
For adults with asymptomatic or mild COVID-19, what are the effects of azithromycin? |
Jane Burch, Sera Tort |
| 41 |
[GO] |
2021―Okt―20 |
What are the effects of colchicine for treatment of asymptomatic or mild COVID-19? |
Jane Burch, Sera Tort |
| 42 |
[GO] |
2021―Okt―20 |
What are the effects of colchicine for treatment of moderate to severe COVID-19? |
Jane Burch, Sera Tort |
| 43 |
[GO] |
2021―Sep―25 |
What are the effects of contact regulation and transmission-reducing measures on COVID-19 in long-term care facilities (LTCFs)? |
Jane Burch, Sera Tort |
| 44 |
[GO] |
2021―Sep―25 |
What are the effects of COVID-19 entry regulation measures in long-term care facilities (LTCFs)? |
Jane Burch, Sera Tort |
| 45 |
[GO] |
2021―Sep―24 |
What are the effects of COVID-19 outbreak control measures in long-term care facilities (LTCFs)? |
Jane Burch, Sera Tort |
| 46 |
[GO] |
2021―Sep―07 |
For adults with asymptomatic or mild COVID-19, what are the effects of SARS-CoV-2-neutralising monoclonal antibodies (alone or combined)? |
Jane Burch, Sera Tort |
| 47 |
[GO] |
2021―Sep―06 |
For adults hospitalized with moderate to severe COVID-19, what are the effects of SARS-CoV-2-neutralising monoclonal antibodies (alone or combined)? |
Jane Burch, Sera Tort |
| 48 |
[GO] |
2021―Sep―01 |
For people with COVID-19 and terminal disease, what are the effects of pharmacological interventions for palliative symptom control? |
Jane Burch, Sera Tort |
| 49 |
[GO] |
2021―Aug―20 |
For adults hospitalized with acute or suspected COVID-19, what are the benefits and harms of systemic corticosteroids? |
Sera Tort, Jane Burch, Christopher Bunt |
| 50 |
[GO] |
2021―Aug―06 |
What are the effects of remdesivir for the treatment of COVID-19? |
Sera Tort, Christopher Bunt |
| 51 |
[GO] |
2021―Jul―29 |
Does administering post-exposure ivermectin prevent COVID-19 infection in asymptomatic close household contacts? |
Jane Burch, Sera Tort, Christopher Bunt |
| 52 |
[GO] |
2021―Jul―29 |
For adults with mild or moderate symptomatic COVID-19, what are the effects of ivermectin? |
Jane Burch, Sera Tort, Christopher Bunt |
| 53 |
[GO] |
2021―Mai―26 |
For people with moderate to severe COVID-19, what are the benefits and harms of vitamin D supplementation? |
Sera Tort, Jane Burch |
| 54 |
[GO] |
2021―Mai―26 |
What are the effects of convalescent plasma for people with moderate to severe COVID-19? |
Jane Burch, Christopher Bunt |
| 55 |
[GO] |
2021―Apr―08 |
For adults with COVID-19, what are the effects of the interleukin-6 blocking agents tocilizumab and sarilumab? |
Jane Burch, Sarah El-Nakeep |
| 56 |
[GO] |
2021―Apr―08 |
What are the effects of entry and/or exit screening at international borders on the spread of COVID-19? |
Jane Burch, Smitha Bhat, Christopher Bunt |
| 57 |
[GO] |
2021―Apr―08 |
What are the effects of international travel restrictions on the spread of COVID-19? |
Jane Burch, Smitha Bhat, Christopher Bunt |
| 58 |
[GO] |
2021―Apr―08 |
What are the effects of quarantining travelers crossing international borders (with or without screening) on the spread of COVID-19? |
Jane Burch, Smitha Bhat, Christopher Bunt |
| 59 |
[GO] |
2021―Apr―08 |
What is the accuracy of rapid, point-of-care antigen and molecular-based tests for the diagnosis of SARS-CoV-2 infection? |
Jane Burch, Smitha Bhat |
| 60 |
[GO] |
2021―Mrz―19 |
What are the cardiovascular effects of COVID-19? |
Jane Burch, Sera Tort |
| 61 |
[GO] |
2021―Mrz―19 |
What is the accuracy of chest computed tomography (CT) and chest X-ray for the diagnosis of COVID-19? |
Jane Burch, Kwun M Fong |
| 62 |
[GO] |
2021―Mrz―12 |
What is the accuracy of World Health Organization (WHO)-specified and related COVID-19 symptoms for diagnosis of COVID-19? |
Jane Burch, Christopher Jackson |
| 63 |
[GO] |
2021―Mrz―05 |
For adults with coronavirus disease 2019 (COVID-19), what are the benefits and harms of hydroxychloroquine? |
Sera Tort, Christopher Bunt |
| 64 |
[GO] |
2021―Jan―21 |
What evidence is available on care bundles for improving outcomes in people with COVID-19 in the intensive care unit (ICU)? |
Jane Burch, Sera Tort |
| 65 |
[GO] |
2020―Dez―22 |
What evidence is available on measures implemented in school settings to reopen schools and/or keep schools open during the COVID-19 pandemic? |
Jane Burch, Sera Tort |
| 66 |
[GO] |
2020―Dez―07 |
What is the accuracy of chest computed tomography (CT) for the diagnosis of COVID-19? |
Jane Burch, Kwun M Fong |
| 67 |
[GO] |
2020―Dez―01 |
What is the accuracy of changes in white blood cell (WBC) count for diagnosing COVID-19? |
Jane Burch, Sera Tort |
| 68 |
[GO] |
2020―Nov―13 |
What is the accuracy of immunoglobulin G (IgG) and IgM antibody tests for detection of SARS-CoV-2 infection? |
Jane Burch, Christopher Bunt |
| 69 |
[GO] |
2020―Nov―10 |
What intervention, organizational and individual characteristics impact the implementation of interventions to support frontline health and social care professionals during and after a disease outbreak, epidemic, or pandemic? |
Jane Burch, Sera Tort |
| 70 |
[GO] |
2020―Nov―01 |
What are the effects of prophylactic anticoagulation for people with COVID-19 who need respiratory support? |
Jane Burch, Christopher Bunt |
| 71 |
[GO] |
2020―Okt―22 |
What is the accuracy of chest computed tomography (CT) for the diagnosis of COVID-19? |
Jane Burch, Kwun M Fong |
| 72 |
[GO] |
2020―Okt―22 |
What are the effects of convalescent plasma for people with COVID-19? |
Jane Burch, Christopher Bunt |
| 73 |
[GO] |
2020―Okt―14 |
What are the benefits and harms of Chinese herbs combined with Western medicine for people with severe acute respiratory syndrome (SARS)? |
Sera Tort, Jane Burch |
| 74 |
[GO] |
2020―Okt―09 |
What is the accuracy of symptom screening and elicitation of information about travel history and exposure to a known infected person for diagnosing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection? |
Jane Burch, Smitha Bhat |
| 75 |
[GO] |
2020―Okt―05 |
What are the effects of quarantining travelers crossing international borders on the spread of COVID-19? |
Jane Burch, Smitha Bhat, Christopher Bunt |
| 76 |
[GO] |
2020―Okt―05 |
What are the effects of international travel restrictions on the spread of COVID-19? |
Jane Burch, Smitha Bhat, Christopher Bunt |
| 77 |
[GO] |
2020―Okt―05 |
What are the effects of entry and exit screening at international borders on the spread of COVID-19? |
Jane Burch, Smitha Bhat, Christopher Bunt |
| 78 |
[GO] |
2020―Sep―19 |
What are the effects of quarantine for individuals traveling from a country with a declared COVID-19 outbreak? |
Jane Burch, Christopher Bunt |
| 79 |
[GO] |
2020―Sep―19 |
What are the effects of quarantine for close contacts of people with confirmed COVID-19? |
Jane Burch, Christopher Bunt |
| 80 |
[GO] |
2020―Sep―19 |
What are the effects of quarantine plus other measures for controlling the spread of COVID-19? |
Jane Burch, Christopher Bunt |
| 81 |
[GO] |
2020―Sep―18 |
What is the accuracy of rapid, point-of-care antigen and molecular-based tests for the diagnosis of SARS-CoV-2 infection? |
Jane Burch, Smitha Bhat |
| 82 |
[GO] |
2020―Aug―08 |
How do interventions commonly available during pandemics compare in terms of control of heavy menstrual bleeding? |
Jane Burch, Sera Tort |
| 83 |
[GO] |
2020―Aug―08 |
Can interventions commonly available during pandemics control heavy menstrual bleeding? |
Jane Burch, Sera Tort |
| 84 |
[GO] |
2020―Jul―24 |
What are the effects of convalescent plasma for people with COVID-19? |
Jane Burch, Christopher Bunt |
| 85 |
[GO] |
2020―Jul―17 |
What is the accuracy of World Health Organization (WHO)-specified and related COVID-19 symptoms for diagnosis of COVID-19? |
Jane Burch, Christopher Jackson, Christopher Bunt |
| 86 |
[GO] |
2020―Jul―13 |
What are the effects of convalescent plasma for people with COVID-19? |
Jane Burch, Christopher Bunt |
| 87 |
[GO] |
2020―Apr―20 |
What are the effects of quarantine for individuals traveling from a country with a declared COVID-19 outbreak? |
Jane Burch, Christopher Bunt |
| 88 |
[GO] |
2020―Apr―20 |
What are the effects of quarantine plus other measures for controlling the spread of COVID-19? |
Jane Burch, Christopher Bunt |
| 89 |
[GO] |
2020―Apr―20 |
What are the effects of quarantine for close contacts of people with confirmed COVID-19? |
Jane Burch, Christopher Bunt |
